6. THE EVALUATION OF THE THERAPEUTIC EFFECT OF NON-ALCOHOLIC FATTY LIVER DISEASE OF THE COMBINATION DECOCTION OF CHAIHU SHUGAN TANG AND ERCHEN TANG
Main Article Content
Abstract
Background: Fatty liver disease is characterized by abnormal accumulation of fat in liver cells due to various causes. Modern medicine currently lacks a specific treatment method, mainly focusing on improving diet and exercise. Therefore, researching traditional herbal medicine to support the treatment of fatty liver disease is a new direction.
Objectives: To evaluate the therapeutic effects and monitor any potential adverse effects of the combination of Chaihu Shugan tang and ErChen tang on NAFLD treatment. Subjects and methods: A clinical intervention study was conducted on 35 NAFLD patients using the herbal combination of Chaihu Shugan tang and ErChen tang. Clinical and subclinical outcomes were evaluated through liver ultrasound and various blood biochemical indices, including cholesterol, triglycerides, HDL-C, LDL-C, AST, ALT, and GGT. The study lasted 84 days, from June 2022 to December 2022, at Da Nang Traditional Medicine Hospital.
Results: After the intervention, both clinical and subclinical symptoms were significantly improved. The levels of cholesterol, triglyceride, HDL-C, and LDL-C improved by 28.39%, 30.13%, 11.30%, and 37.08%, respectively. Additionally, there was an 11.28% improvement in AST levels, a 21.53% improvement in ALT levels, and a 21.11% improvement in GGT levels. Statistical significance at p < 0.05.
Conclusion: The herbal combination of Chaihu Shugan tang and ErChen tang effectively improved the clinical symptoms of non-alcoholic fatty liver disease. Subclinically, the combination improved cholesterol, triglycerides, HDL-C, LDL-C, AST, ALT, GGT, and reduced liver fat accumulation on ultrasonography without showing any adverse effects during the study period.
Article Details
Keywords
Chaihu Shugan tang, Er Chen tang, Non-alcoholic fatty liver disease.
References
Nonalcoholic Fatty Liver Disease and
Nonalcoholic Steatohepatitis, World
gastroenterology organisation global guidelines,
2012.
[2] Chalasani Naga, Younossi Zobair, et al., The
diagnosis and management of nonalcoholic
fatty liver disease: practice guidance from the
American Association for the Study of Liver
Diseases, 67(1), pp. 328-357, 2018.
[3] Traditional Chinese Medicine Association,
Guidelines for Diagnosis and treatment of
common Internal Diseases in Chinese Medicine,
China Traditional Chinese Medicine Publishing
House, 2008.
[4] Ministry of Health, Guidelines for Diagnosis
and treatment of internal pathology, Medicine
Publishing House, 2018.
[5] Leoni S, Tovoli F, Napoli L et al., Current
guidelines for the management of non-alcoholic
fatty liver disease: A systematic review with
comparative analysis. World J Gastroenterol
2018; 24(30): 3361-3373, 2018.
[6] Hien TTT, Study on the effects of Ganmo
tablets in the treatment of non-alcoholic fatty
liver disease in clinical practice, Master's thesis
in Medicine, Vietnam Academy of Traditional
Medicine, 2020.
[7] Hou Jie, Clinical observation of Jia jian Erchen
Siwu Tang in the treatment of non-alcoholic
fatty liver disease, Practical Traditional Chinese
Medicine, 37(07), 2021.
[8] He SN, Chen CY, Huang JF et al., Mechanisms
of action and efficacy of Chaihu Shugan san
in the treatment of non-alcoholic fatty liver
disease, Digestive Department of the Hospital of
Traditional Chinese Medicine, Fujian University
of Traditional Chinese Medicine, 2022.